TrovRx, Inc. – Trademark Portfolio

Entity Type: 03

TrovRx, Inc. holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 6 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include ENU. The owner is based in Excelsior, MN.

6035 McKinley Place

Excelsior, MN 55331

10 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

TrovRx, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (6 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

10
Medical Apparatus (3 filings)

Surgical, medical, dental and veterinary apparatus and instruments

29
Meats & Processed Foods (1 filing)

Meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits

Frequently Asked Questions

How many trademarks does TrovRx, Inc. have?

TrovRx, Inc. has 10 U.S. trademarks filed with the USPTO. Of these, 1 registered, 5 abandoned, 4 cancelled.

What trademark classes does TrovRx, Inc. file in?

TrovRx, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 29 (Meats & Processed Foods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are TrovRx, Inc.'s most well-known trademarks?

TrovRx, Inc.'s registered trademark portfolio includes well-known marks such as ENU. These are among 1 currently registered trademark in the portfolio.

What is TrovRx, Inc.'s trademark registration success rate?

TrovRx, Inc. has a 10% trademark registration rate, with 1 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.